title: Stroke prevention in women: synopsis of the 2014 American Heart Association/American Stroke Association guideline.
abstract: METHODS
  In February 2014, the American Heart Association/American Stroke Association released their first guideline focused on stroke prevention in women. This new guideline highlights unique risk factors for stroke in women, including oral contraception and hormone therapy, and pregnancy-associated disorders, such as preeclampsia, that may have long-lasting consequences on a woman's health. It also addresses hypertension; atrial fibrillation; migraine headache with aura; and the epidemiology of types of stroke, such as aneurysmal subarachnoid hemorrhage and cerebral vein thrombosis, that are predominant in women.
  
  
  METHODS
  Members of a multidisciplinary expert panel searched, reviewed, and critiqued relevant English-language literature published between 1990 and May 2013. The panel devised evidence tables and developed recommendations using American Heart Association guideline procedures and levels of evidence.
  
  
  CONCLUSIONS
  This synopsis of the guideline summarizes the evidence about risk factors for stroke in women and suggests prevention strategies. It also describes the new recommendations relevant to identifying and treating hypertensive disorders in pregnancy that increase risk for stroke.
authors.forename: Cheryl
authors.initials: C
authors.lastname: Bushnell
authors.forename: Louise
authors.initials: L
authors.lastname: McCullough
mesh_terms: D000572:American Heart Association; D001241:Aspirin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000517:prevention & control; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D014481:United States
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin